Assertion: aplastic anemia | /r/HasProperty | aa
Facets:
Source sentences:
text: Aplastic Anemia (AA) is rare haemopoietic stem cell disorder characterized by pancytopenia in peripheral blood and hypocellular marrow in which normal haemopoietic marrow is replaced by fat cells.
text: It is involved in research and support for aplastic anaemia (AA) and related diseases.
text: Aplastic Anemia (AA)
text: Aplastic anemia (AA)
text: Aplastic anemia (AA) develops when the body fails to make appropriate number of new members cells.
text: Aplastic anemia (AA) is a potentially life-threatening failure of hemopoiesis characterized by pancytopenia and hypocellular bone marrow.
text: Aplastic anemia (AA), also spelled aplastic anaemia, is a disease that occurs when the bone marrow stops producing enough stem cells to make the red blood cells, white blood cells, and platelets that the body needs.
text: Aplastic anemia (AA) can be inherited or acquired.
text: AMG531, generic name: romiplostim (recombinant), 'the drug') for an additional indication of treatment of aplastic anemia (AA) in patients who have had an inadequate response to conventional therapy from Japan's Ministry of Health, Labour and Welfare (MHLW).
text: How do patients with aplastic anemia (AA) fare if they get COVID-19?
text: 2019; 39(2):217-221 [ PubMed Distinguishing between aplastic anemia (AA) and
text: Recurrent ovarian hemorrhage resulting in ovarian infarction may lead to a life-threatening intraperitoneal hemorrhage in women with bleeding disorders such as aplastic anemia (AA).
text: 2018; 40(7):e464-e466 [ PubMed Thymomas are the most common masses located in the anterior mediastinum, and they are often associated with autoimmune disorders including myasthenia gravis, polymyositis, and aplastic anemia (AA).
text: Refractory aplastic anemia (AA) is defined as a lack of response to first-line immunosuppressive therapy (IST) with antithymocyte globulin and cyclosporin and is manifested as persistence of severe cytopenias at 6 months after IST.
text: Refractory aplastic anemia (AA) has been defined as lack of response with persistence of severe pancytopenia at 6 months after 1 course of immunosuppressive therapy (IST).
text: HLA typing of the patient and the family, at the time the patient is diagnosed with aplastic anemia (AA), remains a crucial early diagnostic procedure, and should be considered in every patient up to the age of 60 years.
text: Infection is a major cause of death in patients with aplastic anemia (AA).
text: Current immunosuppressive treatment (IST) induces remissions in 50%-70% of patients with aplastic anemia (AA) and result in excellent long-term survival.
text: In aplastic anemia (AA), immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine A (CsA) produces excellent results.
text: An immune basis for most patients with aplastic anemia (AA) provides a rationale for immunosuppressive therapy (IST), using antithmyocyte globulin and cyclosporine as one therapeutic modality; hematologic response is observed in up to 75% of patients.
text: Fatigue is one of the common symptoms of myelodysplastic syndrome (MDS), aplastic anemia (AA) and paroxysmal nocturnal hemoglobinuria (PNH) along with pain, depression, anxiety and stress.